UBS lowered the firm’s price target on Humana (HUM) to $195 from $285 and keeps a Neutral rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HUM:
- Humana price target lowered to $196 from $260 at BofA
- Humana price target lowered to $201 from $290 at Cantor Fitzgerald
- Humana price target lowered to $250 from $310 at Oppenheimer
- Humana price target lowered to $146 from $174 at Morgan Stanley
- Humana price target lowered to $252 from $312 at Guggenheim